Summary
Liminal BioSciences is a development-stage biopharmaceutical company focused on discovering and developing novel and distinctive small molecule therapeutics that modulate G protein-coupled receptor pathways.
Deals Overview
All rights reserved. Copyright © 2025 Datasite
Senior Management
Kenneth Galbraith
CEO
Bruce Pritchard
CEO
Nicole Rusaw
CFO
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy